Protection against oxaliplatin acute neurosensory toxicity by venlafaxine
- 1 July 2003
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Anti-Cancer Drugs
- Vol. 14 (6), 423-425
- https://doi.org/10.1097/00001813-200307000-00006
Abstract
Venlafaxine (Effexor; Wyeth Lederlé) has previously shown therapeutic effects for the management of chronic and neuropathic pains. We report here the efficacy of venlafaxine upon acute neurosensory symptoms secondary to oxaliplatin toxicity. A dose of 50 mg of venlafaxine was given orally at the beginning of the oxaliplatin infusion. Patients did not experience any or very low paresthesias, even in the cold. As the results were very dramatic and reproducible, we propose that venlafaxine may be of use in the daily management of oxaliplatin-related neurosensory toxicity.Keywords
This publication has 23 references indexed in Scilit:
- Topotecan preceded by oxaliplatin using a 3 week schedule: a phase I study in advanced cancer patientsEuropean Journal of Cancer, 2002
- Exacerbation of oxaliplatin neurosensory toxicity following surgeryAnnals of Oncology, 2002
- Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxineAnti-Cancer Drugs, 2002
- Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: A phase I study in advanced gastrointestinal cancer patientsAnnals of Oncology, 2000
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000
- Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules.Diabetes Care, 1999
- Combination of Oxaliplatin Plus Irinotecan in Patients With Gastrointestinal Tumors: Results of Two Independent Phase I Studies With PharmacokineticsJournal of Clinical Oncology, 1999
- Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancerThe Lancet, 1997
- Natural history of patients with untreated liver metastases from colorectal cancerThe American Journal of Surgery, 1981